Researchers have found that, contrary to received wisdom, glycated hemoglobin is an accurate guide to blood glucose levels in patients with cystic fibrosis.
The oral antidiabetic drug repaglinide controls blood glucose levels as effectively as insulin in patients with newly diagnosed cystic-fibrosis-related diabetes, study findings indicate.